Dr. Reddy’s Labs to sell certain rights for ELYXYB to BioDelivery Sciences

Dr. Reddy's Laboratories (Dr. Reddy's Labs) has agreed to divest its US and Canada rights for migraine drug — ELYXYB (celecoxib oral solution) 25 mg/ml, ... Read More